Industry Seeks More Clarity Following Combo Product GMP Final Rule
This article was originally published in The Gray Sheet
Executive Summary
FDA’s final regulation outlines which manufacturing system requirements apply to products that have drug, device and/or biologic components. An industry coalition says key details need to be filled in by FDA with guidance.
You may also be interested in...
FDA Issues Final Guideline On Combination Product GMPs
The document provides real-world tips demonstrating how the agency expects manufacturers to apply GMP rules to combination products. It's linked to a 2013 rule on the subject.
Combo Products Guidance Could Help Point Novel OTC Switches In Right Direction
FDA delivers a draft GMPs guidance for combination products, providing details and examples on how the agency regulates drug delivery devices and other drug/device products. The document could be useful for firms interested in proposing novel Rx-to-OTC switches.
Combo Products Guidance Could Help Point Novel OTC Switches In Right Direction
FDA delivers a draft GMPs guidance for combination products, providing details and examples on how the agency regulates drug delivery devices and other drug/device products. The document could be useful for firms interested in proposing novel Rx-to-OTC switches.